Immuno-Oncology: Augmenting the Immune System’s Natural Ability to See and Eliminate Cancer

Immuno-Oncology: Augmenting the Immune System’s Natural Ability to See and Eliminate Cancer

0 0 about 1 month ago
7 Plays 57 Downloads
In this edition of The Onco’Zine Brief Peter Hofland talks with Mr. Isaac Israel, the CEO of Kitov Pharma, a pharmaceutical drug development company developing new options to treat osteoarthritis pain and hypertension simultaneously, as well as novel anticancer drugs.

The company is developing an investigational drug called NT-219, a novel small molecule drug designed to targets two signal proteins that are part of an anti-cancer drug resistance mechanism. 
Based on recent findings, Kitov ... See More

Find us on Facebook

Copyright 2019 - Spreaker Inc. a Voxnest Company - Create a podcast - New York, NY
Help